Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05182073
Title FT576 in Subjects With Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fate Therapeutics
Indications

multiple myeloma

Therapies

Cyclophosphamide + Fludarabine

FT576

Daratumumab + FT576

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.